Ebselen Inhibits the Growth of Lung Cancer Cells via Cell Cycle Arrest and Cell Death Accompanied by Glutathione Depletion.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
06 Sep 2023
Historique:
received: 26 07 2023
revised: 04 09 2023
accepted: 05 09 2023
medline: 4 10 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Ebselen is a glutathione (GSH) peroxidase (GPx) mimic originally developed to reduce reactive oxygen species (ROS). However, little is known about its cytotoxicological effects on lung cells. Therefore, this study aimed to investigate the effects of Ebselen on the cell growth and cell death of A549 lung cancer cells, Calu-6 lung cancer cells, and primary normal human pulmonary fibroblast (HPF) cells in relation to redox status. The results showed that Ebselen inhibited the growth of A549, Calu-6, and HPF cells with IC

Identifiants

pubmed: 37764247
pii: molecules28186472
doi: 10.3390/molecules28186472
pmc: PMC10538040
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0
ebselen 40X2P7DPGH
Annexin A5 0
Glutathione GAN16C9B8O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea
ID : 2019R1I1A2A01041209

Références

Biochem Pharmacol. 1984 Oct 15;33(20):3247-50
pubmed: 6593071
Chem Pharm Bull (Tokyo). 2019;67(3):186-191
pubmed: 30827998
Am J Pathol. 2012 Apr;180(4):1340-55
pubmed: 22387320
Free Radic Res. 2022 Jul-Aug;56(7-8):473-482
pubmed: 36562703
J Biol Chem. 2002 Oct 18;277(42):39456-62
pubmed: 12177067
Biochim Biophys Acta. 2006 May-Jun;1757(5-6):509-17
pubmed: 16829228
Int J Mol Sci. 2020 Apr 10;21(7):
pubmed: 32290325
Methods Mol Biol. 2019;1877:1-21
pubmed: 30535995
Science. 1997 Feb 21;275(5303):1129-32
pubmed: 9027314
Int J Oncol. 2014 Jan;44(1):301-8
pubmed: 24172913
Environ Pollut. 2019 May;248:845-856
pubmed: 30856500
Am J Ther. 2002 May-Jun;9(3):225-33
pubmed: 11941382
Curr Hypertens Rep. 2002 Apr;4(2):160-6
pubmed: 11884272
Environ Toxicol. 2018 Apr 30;:
pubmed: 29708299
Mol Cell Biochem. 2011 Mar;349(1-2):179-86
pubmed: 21113647
Toxicol In Vitro. 2010 Jun;24(4):1237-42
pubmed: 20149858
Semin Cell Dev Biol. 2020 Nov;107:28-35
pubmed: 32334991
Biochem Pharmacol. 1984 Oct 15;33(20):3235-9
pubmed: 6487370
Front Microbiol. 2018 Mar 05;9:336
pubmed: 29556223
Mol Cells. 2008 Aug 31;26(2):158-64
pubmed: 18596414
Cancer Lett. 2007 Jun 18;251(1):68-77
pubmed: 17189668
Am J Health Syst Pharm. 2018 Jul 1;75(13):945-952
pubmed: 29759975
Mol Biol Rep. 2020 Mar;47(3):2205-2215
pubmed: 32095983
Biochem J. 1994 Dec 1;304 ( Pt 2):341-5
pubmed: 7998966
Mucosal Immunol. 2009 Mar;2(2):103-21
pubmed: 19129758
Food Chem Toxicol. 2009 Oct;47(10):2531-8
pubmed: 19622380
Molecules. 2020 Jun 07;25(11):
pubmed: 32517368
Clin Sci (Lond). 2022 Apr 29;136(8):537-555
pubmed: 35343564
Arch Toxicol. 2010 Sep;84(9):689-98
pubmed: 20449726
Trends Cell Biol. 2015 Oct;25(10):592-600
pubmed: 26410405
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8579-84
pubmed: 12070343
Antioxid Redox Signal. 2014 Jan 10;20(2):191-203
pubmed: 23795780
Clin Chest Med. 2020 Mar;41(1):25-38
pubmed: 32008627
Transl Lung Cancer Res. 2019 Dec;8(6):1091-1106
pubmed: 32010587
Free Radic Biol Med. 2018 Nov 1;127:238-247
pubmed: 29807162
Annu Rev Physiol. 1998;60:619-42
pubmed: 9558479
Arch Biochem Biophys. 2016 Apr 1;595:109-12
pubmed: 27095225
Diabetes. 2013 Oct;62(10):3582-8
pubmed: 23801580
Lung Cancer. 2009 Aug;65(2):150-60
pubmed: 19111365
Int J Oncol. 2016 May;48(5):2197-204
pubmed: 26936390
Cancer Cell. 2020 Aug 10;38(2):167-197
pubmed: 32649885
Biochim Biophys Acta. 1994 Jul 14;1213(2):176-82
pubmed: 8025128
Oncol Rep. 2018 Sep;40(3):1787-1794
pubmed: 29956787

Auteurs

Woo Hyun Park (WH)

Department of Physiology, Medical School, Jeonbuk National University, 20 Geonji-ro, Deokjin, Jeonju 54907, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH